Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...

Foreigner were welcomed into the Rock & Roll Hall Of Fame this year, but the band didn’t feel very welcomed. Drummer Dennis ...

A year after administration of a mesencephalon dopamine nerve cell therapy derived from embryonic stem cells, it was ...

On Monday, AbbVie Inc (NYSE:ABBV) stock plunged after two trials investigating emraclidine as a once-daily, oral monotherapy ...

Vesalius will lead the drug discovery process to identify drugs for Parkinson’s disease and a second ... have been focused on advancing our platform to generate breakthrough treatments for common ...

Researchers have identified a protein, TMEM16F, that appears to aid the spread of Parkinson’s pathology in the brain.

Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product revenue for neffy sales, which reflects revenues from only one week following ...

Scans revealed bleeding in the lower-left half of his brain. The diagnosis: The man had an intracerebral hemorrhage (ICH), a ...